Editorial: Women in science: pharmacological treatment of pain

Other authors

Institut Català de la Salut

[Araya EI] Grup de Recerca en Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Chichorro JG] Department of Pharmacology, Biological Sciences Sector, Federal University of Parana, Curitiba, Brazil

Vall d'Hebron Barcelona Hospital Campus

Publication date

2023-08-22T11:54:37Z

2023-08-22T11:54:37Z

2023-06-27



Abstract

Chronic pain; Depression; Ketamine


Dolor crònic; Depressió; Ketamina


Dolor crónico; Depresión; Ketamina


This study showed that both ketamine and lidocaine infusion was able to reduce mean daily morphine consumption by 28% and 23%, respectively. This finding provided a useful therapeutic approach to improve analgesia and decrease opioid consumption, which may be extremely relevant, especially for patients in need of long-term opioid use.


JGC is recipient of a research productivity fellowship from CNPq (National Council for Scientific and Technological Development, Brazil).

Document Type

Article


Published version

Language

English

Publisher

Frontiers Media

Related items

Frontiers in Pain Research;4

https://doi.org/10.3389/fpain.2023.1231281

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)